These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7347082)

  • 21. Clinical experience and experimental findings with sodium fluoride in otosclerosis (otospongiosis).
    Causse J; Chevance LG; Shambaugh GE
    Ann Otol Rhinol Laryngol; 1974; 83(5):643-7. PubMed ID: 4412470
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biological bases for a fluoride treatment of otospongiosis. Experimental and clinical results].
    Causse J; Chevance LG
    Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):139-60. PubMed ID: 4717370
    [No Abstract]   [Full Text] [Related]  

  • 23. Further experiences with moderate dosage sodium fluoride for sensorineural hearing loss, tinnitus and vertigo due to otospongiosis.
    Shambaugh GE
    Adv Otorhinolaryngol; 1977; 22():35-42. PubMed ID: 868707
    [No Abstract]   [Full Text] [Related]  

  • 24. Sodium fluoride therapy.
    Causse JR; Causse JB; Uriel J; Berges J; Shambaugh GE; Bretlau P
    Am J Otol; 1993 Sep; 14(5):482-90. PubMed ID: 8122713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult fluoride therapy for ostosclerosis (otospongiosis).
    Shambaugh GE
    Arch Otolaryngol; 1983 May; 109(5):353. PubMed ID: 6847492
    [No Abstract]   [Full Text] [Related]  

  • 26. [Status of hearing in patients with otosclerosis shortly after conservative therapy with sodium fluoride].
    Galochkin VI
    Vestn Otorinolaringol; 1986; (4):34-8. PubMed ID: 3750615
    [No Abstract]   [Full Text] [Related]  

  • 27. Sodium fluoride as a treatment for otosclerotic hearing loss.
    Linthicum FH; Forquer BD
    Am J Otol; 1985 Jan; 6(1):35-7. PubMed ID: 3976857
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical Management of Otosclerosis.
    de Oliveira Penido N; de Oliveira Vicente A
    Otolaryngol Clin North Am; 2018 Apr; 51(2):441-452. PubMed ID: 29502728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of fluoride therapy for otosclerosis.
    Snow JB
    Am J Otol; 1985 Jan; 6(1):56-8. PubMed ID: 3976859
    [No Abstract]   [Full Text] [Related]  

  • 30. Otospongiosis as a genetic disease. Early detection, medical management, and prevention.
    Causse JR; Causse JB
    Am J Otol; 1984 Jan; 5(3):211-23. PubMed ID: 6372501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Importance of histologic examination of footplate pieces to provide an indication for postoperative sodium fluoride. Study of 58 stapedectomies].
    Cura O; Gunhan O; Palandoken M; Olgun L; Oztop F
    Rev Laryngol Otol Rhinol (Bord); 1982; 103(3):203-6. PubMed ID: 7156539
    [No Abstract]   [Full Text] [Related]  

  • 32. [Otospongiosis has a genetic disease its early detection its medical management (author's transl)].
    Causse JR; Causse JB
    Ann Otolaryngol Chir Cervicofac; 1980; 97(4-5):325-51. PubMed ID: 7406415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorides for otospongiosis and other osteoporotic states.
    Shambaugh GE
    Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):129-38. PubMed ID: 4717369
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of sodium fluoride on otosclerotic activity as determined by strontium.
    Linthicum FH; House HP; Althaus SR
    Ann Otol Rhinol Laryngol; 1973; 82(4):609-15. PubMed ID: 4721187
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluoride therapy for otosclerosis.
    Kerr GS; Hoffman GS
    Ear Nose Throat J; 1989 Jun; 68(6):426, 428-9. PubMed ID: 2663438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium fluoride and the otosclerotic lesion.
    House HP; Linthicum FH
    Arch Otolaryngol; 1974 Dec; 100(6):427-30. PubMed ID: 4447482
    [No Abstract]   [Full Text] [Related]  

  • 37. Sodium fluoride therapy for otosclerosis.
    Kornblut AD
    Arch Otolaryngol Head Neck Surg; 1991 Apr; 117(4):450-1. PubMed ID: 2007023
    [No Abstract]   [Full Text] [Related]  

  • 38. Cochlear otospongiosis etiology, diagnosis and therapeutic implications.
    Causse J; Shambaugh GE; Chevance LG; Bretlau P
    Adv Otorhinolaryngol; 1977; 22():43-56. PubMed ID: 868708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New concepts in management of otospongiosis.
    Shambaugh GE; causse J; Petrovic A; Chevance LG; Valvassori GE
    Arch Otolaryngol; 1974 Dec; 100(6):419-26. PubMed ID: 4447481
    [No Abstract]   [Full Text] [Related]  

  • 40. [Production and clinical study of sodium fluoride tablets in the treatment of otosclerosis].
    Nidzović Z; Macić I; Bodiroga M; Mogorović M; Ivanović A
    Vojnosanit Pregl; 1990; 47(5):352-4. PubMed ID: 2288111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.